Rheo provides an all-in-one device that continuously captures vital signs and applies AI algorithms to generate predictive health insights. The platform delivers higher‑quality, real‑time data to physicians, reduces manual monitoring workload for nurses, and lowers per‑patient costs for hospitals. Patients benefit from more convenient monitoring and improved clinical outcomes.
Funding
$3.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Manually collecting patient vital signs in hospitals is time-consuming for nurses, costly for hospitals, and provides infrequent data, potentially leading to delayed detection of critical changes in patient condition. The current process relies on periodic spot checks, resulting in gaps in data and a reactive approach to patient care.
Solution
Rheo offers a wearable, all-in-one device that continuously streams patient vital signs data to the cloud, providing doctors with more timely and comprehensive data for improved decision-making. By automating vital signs monitoring, Rheo aims to reduce the workload for nurses, allowing them to focus on other critical tasks. The system's next-generation algorithms analyze the continuous data stream to provide predictive insights, enabling proactive intervention and potentially improving patient outcomes while reducing hospital costs.
Target Audience
The primary target audience includes hospitals, hospital administrators, nurses, and physicians seeking to improve patient monitoring, reduce costs, and enhance the quality of care.
Features
- Continuous, real-time monitoring of vital signs.
- Wireless data transmission to a secure cloud platform.
- AI-powered algorithms for predictive analysis and early warning alerts.
- Integration with existing hospital systems and electronic health records (EHRs).
- User-friendly interface for nurses and physicians to access patient data and insights.